NCT06962163View on ClinicalTrials.gov

Prospective Study, Assessing Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2029

Conditions
Metastatic Breast Cancer
Interventions
DIAGNOSTIC_TEST

[68Ga]Ga-PentixaFor PET/CT

\[68Ga\]Ga-PentixaFor PET-CT is performed after patient inclusion. The patient is treated as per standard of care until disease progression. Then another \[68Ga\]Ga-PentixaFor PET-CT is performed.

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER